This statistic depicts the average number of years from orphan drug designation to last remaining exclusivity as of November 2018, by current exclusivity status. According to the data, drugs that were facing generic/biosimilar competition had an average of 12 years from designation to last remaining exclusivity.
Average time from orphan drug designation to last remaining exclusivity in the U.S. as of 2018, by current status
ODE = orphan drug exclusivity.
Patent protection includes other forms of market exclusivity (e.g., pediatric extension, 505(b)(2)). Comparison of
latest patent and earliest orphan exclusivity dates as the determination of longer duration.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
IQVIA. (December 17, 2018). Average time from orphan drug designation to last remaining exclusivity in the U.S. as of 2018, by current status [Graph]. In Statista. Retrieved October 02, 2024, from https://www.statista.com/statistics/979835/orphan-drug-time-to-last-exclusivity-by-current-status/
IQVIA. "Average time from orphan drug designation to last remaining exclusivity in the U.S. as of 2018, by current status." Chart. December 17, 2018. Statista. Accessed October 02, 2024. https://www.statista.com/statistics/979835/orphan-drug-time-to-last-exclusivity-by-current-status/
IQVIA. (2018). Average time from orphan drug designation to last remaining exclusivity in the U.S. as of 2018, by current status. Statista. Statista Inc.. Accessed: October 02, 2024. https://www.statista.com/statistics/979835/orphan-drug-time-to-last-exclusivity-by-current-status/
IQVIA. "Average Time from Orphan Drug Designation to Last Remaining Exclusivity in The U.S. as of 2018, by Current Status." Statista, Statista Inc., 17 Dec 2018, https://www.statista.com/statistics/979835/orphan-drug-time-to-last-exclusivity-by-current-status/
IQVIA, Average time from orphan drug designation to last remaining exclusivity in the U.S. as of 2018, by current status Statista, https://www.statista.com/statistics/979835/orphan-drug-time-to-last-exclusivity-by-current-status/ (last visited October 02, 2024)
Average time from orphan drug designation to last remaining exclusivity in the U.S. as of 2018, by current status [Graph], IQVIA, December 17, 2018. [Online]. Available: https://www.statista.com/statistics/979835/orphan-drug-time-to-last-exclusivity-by-current-status/